Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
On 9 October 2015, the United Kingdom notified the appearance of an unusual late complication, more than eight months after initial recovery, in an Ebola survivor who was infected while working as a healthcare worker in West Africa.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
This is the 12th update of the rapid risk assessment on the outbreak of Ebola virus disease in West Africa. It provides the latest figures on cases for the week 14-21 June 2015, re-assesses the risk of importation of Ebola virus disease into the EU and discusses options for risk reduction.
Following an invitation from the Portuguese public health authorities, an ECDC team visited Lisbon to conduct a review of Portugal’s emergency preparedness systems for imported cases of viral haemorrhagic fever (Ebola).